STAY
INFORMED
Find our latest news and company updates and access our digital media assets here.
For all media inquiries, contact us at communications@sonicincytes.com or refer to our Media Kit for more information.
Categories
February 15, 2021
Live Webinar: The Role of Next-Gen NITs in NAFLD/NASH
Sonic Incytes Medical Corp. is pleased to host a live educational webinar on The Role of Next-Gen Non-Invasive Tests (NITs)...
February 4, 2021
Further Studies Underway to Demonstrate Clinical Value of VelacurTM
Sonic Incytes is proud to expand its collaboration with key centers of clinical excellence in chronic liver disease in North...
January 6, 2021
Sonic Incytes Introduces VelacurTM at 2021 Digital Medicine & Medtech Showcase
Sonic Incytes Medical Corp. is pleased to present its breakthrough liver health assessment solution, VelacurTM, at the Digital Medicine &...
December 2020
Sonic Incytes Corporate Fact Sheet
At Sonic Incytes, we believe in creating accessible and affordable solutions for healthcare providers – with health insights they can...
November 16, 2020
VelacurTM Results Presented at AASLD’s The Liver Meeting 2020
At the American Association for the Study of Liver Diseases’ (AASLD) The Liver Meeting 2020, Sonic Incytes presented the results...
Oct 28, 2020
Register for Elastography Webinar Series
During The Liver Meeting Digital Experience™ 2020, Sonic Incytes Medical Corp. invites you to a professional development webinar series starting...
Oct 20, 2020
Sonic Incytes Announces FDA Clearance and US Launch of VelacurTM to Help Manage...
Sonic Incytes Medical Corporation is pleased to announce the US commercial release of VelacurTM, the world’s first handheld 3D liver...
October 19, 2020
VelacurTM at AASLD’s The Liver Meeting 2020
Join Sonic Incytes at AASLD’s The Liver Meeting 2020, November 13-16, to find out more about how we’re creating accessible...
August 1, 2020
Visit Us at the Digital International Liver CongressTM
Sonic Incytes is proudly presenting at the EASL Digital International Liver CongressTM, August 27-29, 2020.
May 28, 2020
Genome BC Invests $1M in Breakthrough Solution for Detecting Chronic Liver Disease, Closing...
Genome BC is pleased to announce $1 million in funding to Sonic Incytes Medical Corp., completing the company’s seed financing...
Media Kit
Our media kit includes helpful
materials for reporters.
Get in Touch
Want to find out more?